Breast lumps surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Surgery== | ==Surgery== | ||
Management of breast lumps determined by core needle biopsy:<ref name="pmid25341156">{{cite journal| author=Lehman CD, Lee AY, Lee CI| title=Imaging management of palpable breast abnormalities. | journal=AJR Am J Roentgenol | year= 2014 | volume= 203 | issue= 5 | pages= 1142-53 | pmid=25341156 | doi=10.2214/AJR.14.12725 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25341156 }} </ref> | Management of breast lumps determined by core needle biopsy:<ref name="pmid25341156">{{cite journal| author=Lehman CD, Lee AY, Lee CI| title=Imaging management of palpable breast abnormalities. | journal=AJR Am J Roentgenol | year= 2014 | volume= 203 | issue= 5 | pages= 1142-53 | pmid=25341156 | doi=10.2214/AJR.14.12725 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25341156 }} </ref> | ||
*Atypical ductal [[hyperplasia]] | *Atypical ductal [[hyperplasia]]: | ||
**Excision of lump by surgical consultation and follow-up with clinical breast examination for every 6-12 months accompanied with mammography annually | **Excision of lump by surgical consultation and follow-up with clinical breast examination for every 6-12 months accompanied with mammography annually. | ||
*Atypical lobular [[hyperplasia]], lobular [[neoplasia]], [[lobular carcinoma in situ]] | *Atypical lobular [[hyperplasia]], lobular [[neoplasia]], [[lobular carcinoma in situ]]: | ||
**Surgical consultation and follow-up with clinical breast examination for 6-12 months accompanied with mammography annually | **Surgical consultation and follow-up with clinical breast examination for 6-12 months accompanied with mammography annually. | ||
*Flat [[epithelial]] [[atypia]] | *Flat [[epithelial]] [[atypia]]: | ||
**Surgical consultation and follow-up with clinical breast examination for 6-12 months accompanied with mammography annually | **Surgical consultation and follow-up with clinical breast examination for 6-12 months accompanied with mammography annually. | ||
*[[Papillomas]] | *[[Papillomas]]: | ||
**Multiple, peripheral [[papillomas]],lesions with [[atypia]], and size >10 mm require surgical consultation and Follow-up with clinical breast examination every 12 months and mammography annually | **Multiple, peripheral [[papillomas]],lesions with [[atypia]], and size >10 mm require surgical consultation and Follow-up with clinical breast examination every 12 months and mammography annually. | ||
*Complex sclerosing lesion, radical scar | *Complex sclerosing lesion, radical scar: | ||
**If the size<10mm and adequately sampled, observation would be enough | **If the size<10mm and adequately sampled, observation would be enough. | ||
**If the size>10mm; surgical consultation is | **If the size>10mm; surgical consultation is required. | ||
**If papillomas excised; follow-up with annual clinical breast examination and mammography is required | **If papillomas excised; follow-up with annual clinical breast examination and mammography is required. | ||
*[[Fibroadenoma]] | *[[Fibroadenoma]]: | ||
**If accompanied with atypia and enlarging size, surgical consultation is required | **If accompanied with atypia and enlarging size, surgical consultation is required. | ||
**Follow-up with annual clinical breast examination and mammography | **Follow-up with annual clinical breast examination and mammography. | ||
*Complex [[fibroadenoma]] | *Complex [[fibroadenoma]]: | ||
**Observation and follow-up with clinical breast examination and mammography annually | **Observation and follow-up with clinical breast examination and mammography annually. | ||
*[[Sclerosing adenosis]] | *[[Sclerosing adenosis]]: | ||
**Observation and follow-up with clinical breast examination and mammography annually | **Observation and follow-up with clinical breast examination and mammography annually. | ||
*[[Fat necrosis]] | *[[Fat necrosis]]: | ||
**Observation and follow-up with clinical breast examination and mammography annually | **Observation and follow-up with clinical breast examination and mammography annually. | ||
*Columnar [[cell]] [[hyperplasia]] | *Columnar [[cell]] [[hyperplasia]]: | ||
**Observation and follow-up with clinical breast examination and mammography annually | **Observation and follow-up with clinical breast examination and mammography annually. | ||
*[[Phyllodes tumor]] | *[[Phyllodes tumor]]: | ||
**Surgical consultation is required with follow-up with clinical breast examination and mammography annually. | |||
*[[Desmoid tumor]] and [[mammary]] [[fibromatosis]]: | |||
**Surgical consultation is required with follow-up with clinical breast examination and mammography annually | **Surgical consultation is required with follow-up with clinical breast examination and mammography annually | ||
*Pseudoangiomatous [[stromal]] [[hyperplasia]]: | |||
**In symptomatic and large lesions, surgical consultation is required with annual clinical breast examination and mammography follow-up. | |||
*Pseudoangiomatous [[stromal]] [[hyperplasia]] | *[[Apocrine]] [[metaplasia]]: | ||
**In symptomatic and large lesions, surgical consultation is required with annual clinical breast examination and mammography follow-up | **In discordant and atypic lesions, surgical consultation is required and in case of excision,follow-up with clinical breast examination and mammography annually. | ||
*[[Apocrine]] [[metaplasia]] | |||
**In discordant and atypic lesions, surgical consultation is required and in case of excision,follow-up with clinical breast examination and mammography annually | |||
The final decision for excisional [[biopsy]] is based on recommendations from pathologist,radiologist and surgeons. The decision is made after comprehensive evaluation of clinical,imaging and pathologic findings which help to reach the best possible management for patient care. | The final decision for excisional [[biopsy]] is based on recommendations from pathologist,radiologist and surgeons. The decision is made after comprehensive evaluation of clinical,imaging and pathologic findings which help to reach the best possible management for patient care. | ||
Revision as of 16:03, 7 January 2019
|
Breast lumps Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Breast lumps surgery On the Web |
|
American Roentgen Ray Society Images of Breast lumps surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Surgical management of breast lumps is related to type of masses based on core-needle biopsy. Atypical ductal hyperplasia, atypical lobular hyperplasia, lobular neoplasia, lobular carcinoma in situ, flat epithelial atypia . Multiple, peripheral and atypic papillomas, large sclerosing adenosis and radical scar >10mm, atypic and enlargic fibroadenomas ,Desmoid tumor, mammary fibromatosis, phyllodes tumor, symptomatic and large pseudoangiomatous stromal hyperplasia are required surgical consultation and excision. The rest of breast lumps require observation and follow-up. The final decision for excisional biopsy is based on recommendations from pathologist,radiologist and surgeons.
Surgery
Management of breast lumps determined by core needle biopsy:[1]
- Atypical ductal hyperplasia:
- Excision of lump by surgical consultation and follow-up with clinical breast examination for every 6-12 months accompanied with mammography annually.
- Atypical lobular hyperplasia, lobular neoplasia, lobular carcinoma in situ:
- Surgical consultation and follow-up with clinical breast examination for 6-12 months accompanied with mammography annually.
- Flat epithelial atypia:
- Surgical consultation and follow-up with clinical breast examination for 6-12 months accompanied with mammography annually.
- Papillomas:
- Multiple, peripheral papillomas,lesions with atypia, and size >10 mm require surgical consultation and Follow-up with clinical breast examination every 12 months and mammography annually.
- Complex sclerosing lesion, radical scar:
- If the size<10mm and adequately sampled, observation would be enough.
- If the size>10mm; surgical consultation is required.
- If papillomas excised; follow-up with annual clinical breast examination and mammography is required.
- Fibroadenoma:
- If accompanied with atypia and enlarging size, surgical consultation is required.
- Follow-up with annual clinical breast examination and mammography.
- Complex fibroadenoma:
- Observation and follow-up with clinical breast examination and mammography annually.
- Sclerosing adenosis:
- Observation and follow-up with clinical breast examination and mammography annually.
- Fat necrosis:
- Observation and follow-up with clinical breast examination and mammography annually.
- Columnar cell hyperplasia:
- Observation and follow-up with clinical breast examination and mammography annually.
- Phyllodes tumor:
- Surgical consultation is required with follow-up with clinical breast examination and mammography annually.
- Desmoid tumor and mammary fibromatosis:
- Surgical consultation is required with follow-up with clinical breast examination and mammography annually
- Pseudoangiomatous stromal hyperplasia:
- In symptomatic and large lesions, surgical consultation is required with annual clinical breast examination and mammography follow-up.
- Apocrine metaplasia:
- In discordant and atypic lesions, surgical consultation is required and in case of excision,follow-up with clinical breast examination and mammography annually.
The final decision for excisional biopsy is based on recommendations from pathologist,radiologist and surgeons. The decision is made after comprehensive evaluation of clinical,imaging and pathologic findings which help to reach the best possible management for patient care.
References
- ↑ Lehman CD, Lee AY, Lee CI (2014). "Imaging management of palpable breast abnormalities". AJR Am J Roentgenol. 203 (5): 1142–53. doi:10.2214/AJR.14.12725. PMID 25341156.